These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 27861837

  • 1. Cardiovascular Events, Conditions, and Procedures Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC, Reed ML, Fanning KM, Kurth T, Lipton RB.
    Headache; 2017 Jan; 57(1):31-44. PubMed ID: 27861837
    [Abstract] [Full Text] [Related]

  • 2. Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB, Reed ML, Kurth T, Fanning KM, Buse DC.
    Headache; 2017 Nov; 57(10):1507-1521. PubMed ID: 28990165
    [Abstract] [Full Text] [Related]

  • 3. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC, Serrano D, Reed ML, Kori SH, Cunanan CM, Adams AM, Lipton RB.
    Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
    [Abstract] [Full Text] [Related]

  • 4. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
    Lipton RB, Manack Adams A, Buse DC, Fanning KM, Reed ML.
    Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
    [Abstract] [Full Text] [Related]

  • 5. Factors associated with triptan use in episodic migraine: results from the American Migraine Prevalence and Prevention Study.
    Chu MK, Buse DC, Bigal ME, Serrano D, Lipton RB.
    Headache; 2012 Feb; 52(2):213-23. PubMed ID: 22413150
    [Abstract] [Full Text] [Related]

  • 6. Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB, Buse DC, Serrano D, Holland S, Reed ML.
    Headache; 2013 Sep; 53(8):1300-11. PubMed ID: 23879870
    [Abstract] [Full Text] [Related]

  • 7. Acute treatment optimization in episodic and chronic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Serrano D, Buse DC, Manack Adams A, Reed ML, Lipton RB.
    Headache; 2015 Apr; 55(4):502-18. PubMed ID: 25881676
    [Abstract] [Full Text] [Related]

  • 8. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB, Munjal S, Buse DC, Fanning KM, Bennett A, Reed ML.
    Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
    [Abstract] [Full Text] [Related]

  • 9. Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention Study.
    Lipton RB, Munjal S, Buse DC, Bennett A, Fanning KM, Burstein R, Reed ML.
    Headache; 2017 Jul; 57(7):1026-1040. PubMed ID: 28603893
    [Abstract] [Full Text] [Related]

  • 10. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Lipton RB, Serrano D, Nicholson RA, Buse DC, Runken MC, Reed ML.
    Headache; 2013 Jul; 53(10):1548-63. PubMed ID: 23992516
    [Abstract] [Full Text] [Related]

  • 11. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Holland S, Fanning KM, Serrano D, Buse DC, Reed ML, Lipton RB.
    J Neurol Sci; 2013 Mar 15; 326(1-2):10-7. PubMed ID: 23394974
    [Abstract] [Full Text] [Related]

  • 12. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, Serrano D, Lipton RB.
    Headache; 2013 Sep 15; 53(8):1278-99. PubMed ID: 23808666
    [Abstract] [Full Text] [Related]

  • 13. Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB, Serrano D, Pavlovic JM, Manack AN, Reed ML, Turkel CC, Buse DC.
    Headache; 2014 May 15; 54(5):830-49. PubMed ID: 24527745
    [Abstract] [Full Text] [Related]

  • 14. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
    Lipton RB, Munjal S, Alam A, Buse DC, Fanning KM, Reed ML, Schwedt TJ, Dodick DW.
    Headache; 2018 Oct 15; 58(9):1408-1426. PubMed ID: 30341895
    [Abstract] [Full Text] [Related]

  • 15. Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features.
    Lipton RB, Serrano D, Holland S, Fanning KM, Reed ML, Buse DC.
    Headache; 2013 Jan 15; 53(1):81-92. PubMed ID: 23078241
    [Abstract] [Full Text] [Related]

  • 16. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study.
    Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, Lipton RB.
    Headache; 2012 Jan 15; 52(10):1456-70. PubMed ID: 22830411
    [Abstract] [Full Text] [Related]

  • 17. Opioid use and dependence among persons with migraine: results of the AMPP study.
    Buse DC, Pearlman SH, Reed ML, Serrano D, Ng-Mak DS, Lipton RB.
    Headache; 2012 Jan 15; 52(1):18-36. PubMed ID: 22268775
    [Abstract] [Full Text] [Related]

  • 18. Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Serrano D, Manack AN, Reed ML, Buse DC, Varon SF, Lipton RB.
    Value Health; 2013 Jan 15; 16(1):31-8. PubMed ID: 23337213
    [Abstract] [Full Text] [Related]

  • 19. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey.
    Messali A, Sanderson JC, Blumenfeld AM, Goadsby PJ, Buse DC, Varon SF, Stokes M, Lipton RB.
    Headache; 2016 Feb 15; 56(2):306-22. PubMed ID: 26833083
    [Abstract] [Full Text] [Related]

  • 20. Effects of switching acute treatment on disability in migraine patients using triptans.
    Serrano D, Buse DC, Kori SH, Papapetropoulos S, Cunanan CM, Manack AN, Reed ML, Lipton RB.
    Headache; 2013 Oct 15; 53(9):1415-29. PubMed ID: 23808937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.